Clinical Trial Update: Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in iron-deficient premenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency

Drugs mentioned

• IHAT

Snippet

Sponsor: Nemysis Ltd | Conditions: Iron-deficiency | Phase 3 | Status: COMPLETED